Lassa Fever (Lassa Hemorrhagic Fever) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Lassa Fever (Lassa Hemorrhagic Fever) pipeline market research report provides comprehensive information on the therapeutics under development for Lassa Fever (Lassa Hemorrhagic Fever), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Lassa Fever (Lassa Hemorrhagic Fever) and features dormant and discontinued projects.
Key Targets in the Lassa Fever Pipeline Market
The key targets in the Lassa fever pipeline market are Glycoprotein and RNA Directed RNA Polymerase.
Key MoA Types in the Lassa Fever Pipeline Market
The key MoA types in the Lassa fever pipeline market are RNA Directed RNA Polymerase Inhibitor.
Key RoA Types in the Lassa Fever Pipeline Market
The key RoA types in the Lassa fever pipeline market are intramuscular, oral, intravenous, intradermal, and subcutaneous. Intramuscular has the highest pipeline products in the Lassa fever pipeline market.
Lassa Fever Pipeline Market, by RoA
For more RoA insights, download a free report sample
Key Molecule Types in the Lassa Fever Pipeline Market
The key molecule types in the Lassa fever pipeline market are recombinant vector vaccine, small molecule, vaccine, DNA vaccine, live attenuated vaccine, monoclonal antibody, and mRNA Vaccine. Recombinant Vector Vaccine has the highest pipeline products.
Lassa Fever Pipeline Market, by Molecule Types
For more molecule type insights, download a free report sample
Key Companies in the Lassa Fever Pipeline Market
The key companies in the Lassa fever pipeline market are Helix Biogen Institute, Emergent BioSolutions Inc, Kineta Inc, Curevac NV, FUJIFILM Toyama Chemical Co Ltd, GeoVax Labs Inc, and Globavir Biosciences Inc. Helix Biogen Institute has the highest pipeline products.
Lassa Fever Pipeline Market, by Companies
To know more about companies, download a free report sample
Market report overview
Key targets | Glycoprotein and RNA Directed RNA Polymerase |
Key MoA types | RNA Directed RNA Polymerase Inhibitor |
Key RoA types | Intramuscular, Oral, Intravenous, Intradermal, and Subcutaneous |
Key molecule types | Recombinant Vector Vaccine, Small Molecule, Vaccine, DNA Vaccine, Live Attenuated Vaccine, Monoclonal Antibody, and mRNA Vaccine |
Key companies | Helix Biogen Institute, Emergent BioSolutions Inc, Kineta Inc, Curevac NV, FUJIFILM Toyama Chemical Co Ltd, GeoVax Labs Inc, and Globavir Biosciences Inc |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Emergent BioSolutions Inc
FUJIFILM Toyama Chemical Co Ltd
GeoVax Labs Inc
Globavir Biosciences Inc
Helix Biogen Institute
ImmunityBio Inc
Inovio Pharmaceuticals Inc
Kineta Inc
Themis Bioscience GmbH
Tonix Pharmaceuticals Holding Corp
Zalgen Labs LLC
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Lassa fever pipeline market?
The key targets in the Lassa fever pipeline market are Glycoprotein and RNA Directed RNA Polymerase.
-
What are the key MoA types in the Lassa fever pipeline market?
The key MoA types in the Lassa fever pipeline market are RNA Directed RNA Polymerase Inhibitor.
-
What are the key RoA types in the Lassa fever pipeline market?
The key RoA types in the Lassa fever pipeline market are intramuscular, oral, intravenous, intradermal, and subcutaneous.
-
What are the key molecule types in the Lassa fever pipeline market?
The key molecule types in the Lassa fever pipeline market are recombinant vector vaccine, small molecule, vaccine, DNA vaccine, live attenuated vaccine, monoclonal antibody, and mRNA Vaccine.
-
What are the key companies in the Lassa fever pipeline market?
The key companies in the Lassa fever pipeline market are Helix Biogen Institute, Emergent BioSolutions Inc, Kineta Inc, Curevac NV, FUJIFILM Toyama Chemical Co Ltd, GeoVax Labs Inc, and Globavir Biosciences Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.